Phase 2b Study -Bowel Movement Frequency and Constipation-Related Symptom in Patients with Opioid-Induced Constipation
May. 30, 2013
The TD-1211 Phase 2b study demonstrates increased Bowel Movement Frequency and Constipation-Related Symptom improvement in Patients with Opioid-Induced Constipation.
Theravance-discovered, multivalent, µ-opioid receptor neutral antagonist designed to be peripherally selective:
Non-opioid core
Polar
Hydrophilic
P-gp substrate
